Sanwa Kagaku Kenkyusho Co., Ltd.

Yurie Yamada

Hiroki Nagano

Mitsuaki Takeuchi

Satoko Harada

Yuka Kuno

Toru Izuchi

Toshiyuki Miyazawa

Morio Okabe

Daisuke Kurumazuka

Yukiyasu Asano

Hiroyo Kataoka

Yasushi Ohsawa

Hiroki Fujieda

Nobuyoshi Kasugai

Keita Sakai

Naoki Takahashi

Katsunori Kitamoto

Izumi Gotoh

A compound having a V2 receptor agonistic activity is provided. Providing a pharmaceutical composition which contains, as an active ingredient, a compound represented by general formula (I) described below: [Ris formula described below: (A is a lower alkylene group which may be substituted with lower alkyl group; Ris a hydrogen atom; Ris a hydroxyl group, an aromatic heterocyclic group which may be substituted with lower alkyl group, carbamoyl group); Ris a hydrogen atom or lower alkyl group; Ris lower alkyl group which may be substituted with 1-3 fluorine atoms, or halogen atom; Ris a five-membered aromatic monocyclic heterocyclic group, five-membered non-aromatic monocyclic heterocyclic group, (provided each heterocyclic groups contain at least one nitrogen atom and may be substituted with a lower alkyl group); and Ris a lower alkyl group, halogen atom], or pharmacologically acceptable salt thereof.

Benzoazepine derivative and medical use thereof

Growing community of inventors

Osaka, Japan

Yurie Yamada